Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Chronic Combined Oral Methylphenidate and Fluoxetine Increases Inflammation in Somatosensory and Mesolimbic Brain Regions

Neurochemical Research(2025)10.1007/s11064-025-04608-3Source: DataRank Database

Chronic Combined Oral Methylphenidate and Fluoxetine Increases Inflammation in Somatosensory and Mesolimbic Brain Regions is a research paper published in Neurochemical Research (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:OA: hybridIDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Huy Lu,Abigail M. Lantry,Caleigh Hoerner,George Lagamjis,Shannon G. Klein ORCID

Live enrichment

PubMed:19162232

hybridLicense: cc-by

publisherhttps://link.springer.com/content/pdf/10.1007/s11064-025-04608-3.pdf

publisherhttps://link.springer.com/article/10.1007/s11064-025-04608-3/fulltext.html

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12602612/pdf/11064_2025_Article_4608.pdf